This weeks top stories:the rising demand for lentiviral vectors for in vivo gene therapy and elucidating the aggregation rules for short peptides
?? Trending news from the industry
Fuelled by advances in rare disease treatments and vaccination efforts, Natalia Elizalde Urdiain , CBO at VIVEbiotech, discusses how the market demand for lentiviral vectors is evolving, the new therapeutic areas emerging as potential targets for in vivo gene therapy and the latest technological advancements in the development and delivery of in vivo lentiviral vectors. Read more >>>
In this Q&A, Revolo Biotherapeutics’ CEO, Woody Bryan Bryan, discusses how ‘1104, the Company’s lead candidate for allergic diseases, shifts the immune system from a pro-inflammatory state to a homeostatic state, offering potential remission for allergic conditions. Read more >>>
Introducing Kristina Torfg?rd ! Holding a PhD in Clinical Pharmacology, she has over 30 years’ experience in drug development and is currently CEO of IRLAB Therapeutics. Read more >>>
The findings could aid the design of more stable drugs and improve the understanding of diseases linked to peptide aggregation. Read more >>>
Researchers found that HD can impair early brain development through defects associated with mitochondrial dysfunction. Read more >>>
?? Webinar of the week
领英推荐
Coming up in the next few weeks is our webinar with bit.bio !
Join us for an in-depth webinar on astrocytes, a highly versatile and essential glial cell in the central nervous system (CNS). Two speakers will provide valuable insights into the multifaceted roles of astrocytes in both health and disease and the challenges researchers face when modelling this complex biology in vitro.
?? Listen up!
Our podcast episode "Advanced techniques in toxicity testing" explores how innovative assays and human-relevant cell models are transforming toxicity screening in drug development.
??? Sign up for free!
Sign up here to stay ahead of all the latest breaking news, expert insights and the newest trends in global drug discovery.
Drug Target Review is an essential multimedia resource which is trusted and recognised globally of researchers and scientific leaders who cover the most up-to-date innovations, and cutting edge technologies in the industry.